Amgen (AMGN) Presents Several Sub-Analyses at American Society for Bone and Mineral Research From the Ongoing Open-Label Extension Study of the Pivotal Phase 3 Prolia Fracture Trial
10/15/2012 10:37:08 AM
More...
|
Radius Announces Upcoming Scientific Presentations at the American Society for Bone and Mineral Research 2012 Annual Meeting
10/15/2012 9:15:02 AM
More...
|
New Data on Odanacatib, Merck & Co., Inc. (MRK)'s Phase III Investigational Cat-K Inhibitor for Osteoporosis, Presented at the Annual Meeting of American Society for Bone and Mineral Research
9/20/2011 9:35:09 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Highlights Hypoparathyroidism Data to be Presented at Annual Meeting of American Society for Bone and Mineral Research
9/19/2011 9:08:28 AM
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Announces Hypoparathyroidism Data to be Presented at Annual Meeting of American Society for Bone and Mineral Research
9/8/2011 10:35:29 AM
More...
|
American Society for Bone and Mineral Research: Low Sodium May Boost Fracture Risk, Erasmus Medical Center Daniel den Hoed Cancer Center Study
10/20/2010 6:55:16 AM
More...
|
New Data on Odanacatib, Merck Sharp & Dohme (MRK)'s Investigational Cathepsin-K Inhibitor for Osteoporosis, Presented at Merck & Co., Inc. (MRK) Annual Meeting
10/19/2010 9:22:10 AM
More...
|
American Society for Bone and Mineral Research: Novel Drug Promising in Osteoporosis, University of Erlangen Study Reveals
10/19/2010 7:16:36 AM
More...
|
American Society for Bone and Mineral Research: Bone Drug Raises Quality of Life, McMaster University Study
10/19/2010 7:02:43 AM
More...
|
Amgen (AMGN) Highlights Data to Be Presented at American Society for Bone and Mineral Research Meeting
10/15/2010 6:58:25 AM
More...
|
|